Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationLeukemiaBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingCyclophosphamideHistocompatibilityTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone Marrow DiseasesCombined Modality TherapyKidney TransplantationHematopoiesisRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation ChimeraTime FactorsTreatment OutcomeBone Marrow ExaminationRemission InductionHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionBone RemodelingBone Marrow NeoplasmsHepatic Veno-Occlusive DiseaseSurvival AnalysisAcute DiseaseTransplantation ImmunologyGraft vs Host ReactionRetrospective StudiesImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayLeukocyte TransfusionT-LymphocytesHeart TransplantationFlow CytometryMyelodysplastic SyndromesCell DifferentiationChimeraSevere Combined ImmunodeficiencyHLA AntigensSurvival RateFollow-Up StudiesAntineoplastic AgentsBreast NeoplasmsCell ProliferationMice, Inbred BALB CLung TransplantationActuarial AnalysisHematologic DiseasesCyclosporineBone DensityCytarabineLymphocyte TransfusionDisease-Free SurvivalPrognosisTumor Cells, CulturedApoptosisNeoplasmsNuclear FamilyCarmustineEtoposideCell Line, TumorPancytopeniaOrgan TransplantationCell DivisionLeukocyte CountGraft vs Leukemia EffectCells, CulturedGraft vs Tumor EffectGranulocyte Colony-Stimulating FactorAntibodies, MonoclonalSpleenLymphomaCell SurvivalLeukemia, LymphoidCytomegalovirus Infections